PremiumCompany AnnouncementsDr. Reddy’s Laboratories Faces Tax Reassessment Notice Post-Merger Dr. Reddy’s Laboratories Completes Sale of Louisiana Subsidiary Dr. Reddy’s Laboratories Schedules Board Meeting and Trading Window Closure PremiumCompany AnnouncementsDr. Reddy’s Laboratories to Engage with Investors at Upcoming Conference Dr. Reddy’s Faces Tax Penalty, Evaluates Appeal Dr. Reddy’s Laboratories Receives Positive USFDA Inspection Outcome PremiumThe FlyDr. Reddy’s enters commercialization agreement with Henlius for HLX15 Dr. Reddy’s Laboratories Schedules Investor Conference Participation Dr. Reddy’s Laboratories to Engage with Investors in Mumbai Conference